Purinergic Signalling and the Nervous System

In the first 20 years that followed the purinergic signalling hypothesis in 1972, most scientists were sceptical about its validity, largely because ATP was so well established as an intracellular molecule involved in cell biochemistry and it seemed unlikely that such a ubiquitous molecule would act...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Burnstock, Geoffrey (Συγγραφέας), Verkhratsky, Alexei (Συγγραφέας)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2012.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03547nam a22004215i 4500
001 978-3-642-28863-0
003 DE-He213
005 20130726225941.0
007 cr nn 008mamaa
008 120604s2012 gw | s |||| 0|eng d
020 |a 9783642288630  |9 978-3-642-28863-0 
024 7 |a 10.1007/978-3-642-28863-0  |2 doi 
040 |d GrThAP 
050 4 |a QP34-38 
072 7 |a MFG  |2 bicssc 
072 7 |a MED075000  |2 bisacsh 
082 0 4 |a 612  |2 23 
100 1 |a Burnstock, Geoffrey.  |e author. 
245 1 0 |a Purinergic Signalling and the Nervous System  |h [electronic resource] /  |c by Geoffrey Burnstock, Alexei Verkhratsky. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2012. 
300 |a XVIII, 715 p. 135 illus., 46 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Introduction -- Early history of purinergic signaling -- Purinergic cotransmission -- Mechanisms of ATP release and inactivation -- Receptors for purines and pyrimidines -- Evolution of purinergic signaling -- Peripheral nervous system -- Purinergic signalling in the central nervous system -- Sensory Nerves -- Special senses -- Ontogeny of purinergic neurotransmission. 
520 |a In the first 20 years that followed the purinergic signalling hypothesis in 1972, most scientists were sceptical about its validity, largely because ATP was so well established as an intracellular molecule involved in cell biochemistry and it seemed unlikely that such a ubiquitous molecule would act as an extracellular signalling molecule. However, after the receptors for ATP and adenosine were cloned and characterized in the early 1990s and ATP was established as a synaptic transmitter in the brain and sympathetic ganglia, the tide turned. More recently it has become clear that ATP is involved in long-term (trophic) signalling in cell proliferation, differentiation and death, in development and regeneration, as well as in short-term signalling in neurotransmission and secretion. Also, important papers have been published showing the molecular structure of P2X receptors in primitive animals like Amoeba and Schistosoma, as well as green algae. This has led to the recognition of the widespread nature of the purinergic signalling system in most cell types and to a rapid expansion of the field, including studies of the pathophysiology as well as physiology and exploration of the therapeutic potential of purinergic agents. In two books, Geoffrey Burnstock and Alexej Verkhratsky have aimed at drawing together the massive and diverse body of literature on purinergic signalling. The topic of this first book is purinergic signalling in the peripheral and central nervous systems and in the individual senses. In a second book the authors focus on purinergic signalling in non-excitable cells, including those of the airways, kidney, pancreas, endocrine glands and blood vessels. Diseases related to these systems are also considered. 
650 0 |a Medicine. 
650 0 |a Human physiology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Human Physiology. 
700 1 |a Verkhratsky, Alexei.  |e author. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642288623 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-28863-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)